• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical performance of a novel hybrid IVUS-OCT system: a multicentre, randomised, non-inferiority trial (PANOVISION).

作者信息

Jia Haibo, Zhao Chen, Yu Huai, Wang Zhao, Liu Huimin, Xu Maoen, Hu Sining, Li Lulu, He Luping, Weng Ziqian, Qin Yuhan, Xu Yishuo, Zeng Ming, Su Xi, Liu Bin, Hou Jingbo, Yu Bo

机构信息

Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.

The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.

出版信息

EuroIntervention. 2023 Jul 17;19(4):e318-e320. doi: 10.4244/EIJ-D-22-01058.

DOI:10.4244/EIJ-D-22-01058
PMID:37057604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10333919/
Abstract
摘要

相似文献

1
Clinical performance of a novel hybrid IVUS-OCT system: a multicentre, randomised, non-inferiority trial (PANOVISION).一种新型血管内超声-光学相干断层扫描混合系统的临床性能：一项多中心、随机、非劣效性试验（PANOVISION）
EuroIntervention. 2023 Jul 17;19(4):e318-e320. doi: 10.4244/EIJ-D-22-01058.
2
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.光学相干断层成像术与血管内超声和血管造影指导冠状动脉支架置入术的比较（ILUMIEN III：OPTIMIZE PCI）：一项随机对照试验。
Lancet. 2016 Nov 26;388(10060):2618-2628. doi: 10.1016/S0140-6736(16)31922-5. Epub 2016 Oct 30.
3
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.非常薄的支撑物可生物降解聚合物依维莫司洗脱和西罗莫司洗脱支架与全人群冠心病使用耐用聚合物佐他莫司洗脱支架（BIO-RESORT）：一项三臂、随机、非劣效试验。
Lancet. 2016 Nov 26;388(10060):2607-2617. doi: 10.1016/S0140-6736(16)31920-1. Epub 2016 Oct 30.
4
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.在所有需要经皮冠状动脉介入治疗的患者中（荷兰 PEERS 研究），第三代佐他莫司洗脱和依维莫司洗脱支架的应用：一项随机、单盲、多中心、非劣效性试验。
Lancet. 2014 Feb 1;383(9915):413-23. doi: 10.1016/S0140-6736(13)62037-1. Epub 2013 Oct 31.
5
Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial.药物洗脱支架置入术后 ST 段抬高型心肌梗死（DAPT-STEMI）患者 6 个月与 12 个月双联抗血小板治疗：随机、多中心、非劣效性试验。
BMJ. 2018 Oct 2;363:k3793. doi: 10.1136/bmj.k3793.
6
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.靶向治疗联合局部无内膜覆盖槽、低剂量西罗莫司洗脱、可生物降解聚合物冠状动脉支架（TARGET All Comers）：一项多中心、开放标签、随机非劣效性试验。
Lancet. 2018 Sep 29;392(10153):1117-1126. doi: 10.1016/S0140-6736(18)31649-0. Epub 2018 Sep 3.
7
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers.前瞻性多中心随机上市后试验光学相干断层成像子研究，评估 Firehawk 钴铬雷帕霉素靶向洗脱冠状动脉支架系统治疗动脉粥样硬化病变的安全性和有效性：TARGET 所有患者。
EuroIntervention. 2018 Nov 20;14(10):1121-1128. doi: 10.4244/EIJ-D-18-00226.
8
Intravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial.两种腔内涂覆可生物降解聚合物的金属雷帕霉素洗脱支架的血管内成像比较：DESTINY试验的血管内超声（IVUS）和光学相干断层扫描（OCT）结果
Int J Cardiovasc Imaging. 2017 Feb;33(2):161-168. doi: 10.1007/s10554-016-0992-z. Epub 2016 Oct 6.
9
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.载西罗莫司的可生物吸收聚合物涂层支架（MiStent）与载依维莫司的持久聚合物涂层支架（Xience）治疗经皮冠状动脉介入治疗后的疗效比较（DESSOLVE III）：一项随机、单盲、多中心、非劣效、3 期临床试验。
Lancet. 2018 Feb 3;391(10119):431-440. doi: 10.1016/S0140-6736(17)33103-3. Epub 2017 Dec 5.
10
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.超薄支架可生物降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架经皮冠状动脉血运重建（BIOSCIENCE）：一项随机、单盲、非劣效性试验。
Lancet. 2014 Dec 13;384(9960):2111-22. doi: 10.1016/S0140-6736(14)61038-2. Epub 2014 Sep 1.

引用本文的文献

1
From Vision to Illumination: The Promethean Journey of Optical Coherence Tomography in Cardiology.从愿景到启示：光学相干断层扫描在心脏病学中的普罗米修斯之旅。
J Clin Med. 2025 Aug 2;14(15):5451. doi: 10.3390/jcm14155451.
2
Intracoronary Optical Coherence Tomography: Technological Innovations and Clinical Implications in Cardiology.冠状动脉内光学相干断层扫描：心脏病学中的技术创新与临床意义
Curr Treat Options Cardiovasc Med. 2025;27(1):44. doi: 10.1007/s11936-025-01103-4. Epub 2025 Jul 24.
3
Advances in the Detection and Management of Vulnerable Coronary Plaques.易损冠状动脉斑块的检测与管理进展
Circ Cardiovasc Interv. 2025 Aug;18(8):e015529. doi: 10.1161/CIRCINTERVENTIONS.125.015529. Epub 2025 Jul 28.
4
Advantages of hybrid intravascular ultrasound-optical coherence tomography system in clinical practice.混合式血管内超声-光学相干断层扫描系统在临床实践中的优势。
Front Cardiovasc Med. 2025 Jul 4;12:1595889. doi: 10.3389/fcvm.2025.1595889. eCollection 2025.
5
Optical theranostics in ischemic heart disease: from molecular insights to clinical translation.缺血性心脏病中的光学诊疗：从分子洞察到临床转化
Theranostics. 2025 Jun 9;15(14):6789-6817. doi: 10.7150/thno.114307. eCollection 2025.
6
A Multicenter Feasibility and Safety Study of a Novel Hybrid IVUS-OCT Imaging System.一种新型血管内超声-光学相干断层扫描混合成像系统的多中心可行性与安全性研究。
JACC Asia. 2025 Mar;5(3 Pt 1):396-400. doi: 10.1016/j.jacasi.2025.01.009.
7
OUFR Versus FFR for Functional Assessment of Coronary Artery Stenosis in Patients With Unstable Angina.不稳定型心绞痛患者冠状动脉狭窄功能评估中OUFR与FFR的比较
JACC Asia. 2025 Feb;5(2):231-241. doi: 10.1016/j.jacasi.2024.10.026. Epub 2025 Jan 14.
8
Three-dimensional optical coherence tomography for guidance of percutaneous coronary intervention for coronary bifurcation disease: a review of current clinical applications.用于冠状动脉分叉病变经皮冠状动脉介入治疗指导的三维光学相干断层扫描：当前临床应用综述
Cardiovasc Diagn Ther. 2024 Oct 31;14(5):949-957. doi: 10.21037/cdt-24-163. Epub 2024 Oct 18.
9
Emerging Hybrid Intracoronary Imaging Technologies and Their Applications in Clinical Practice and Research.新兴的冠状动脉混合成像技术及其在临床实践和研究中的应用。
JACC Cardiovasc Interv. 2024 Sep 9;17(17):1963-1979. doi: 10.1016/j.jcin.2024.07.007.
10
Coronary calcifications, the Achilles heel in coronary interventions.冠状动脉钙化是冠状动脉介入治疗中的致命弱点。
Postepy Kardiol Interwencyjnej. 2024 Mar;20(1):1-17. doi: 10.5114/aic.2024.136415. Epub 2024 Mar 15.

本文引用的文献

1
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
EuroIntervention. 2019 Feb 20;14(14):1435-1534. doi: 10.4244/EIJY19M01_01.
2
First-in-Human Images of Coronary Atherosclerosis and Coronary Stents Using a Novel Hybrid Intravascular Ultrasound and Optical Coherence Tomographic Catheter.使用新型血管内超声与光学相干断层成像混合导管获得的冠状动脉粥样硬化和冠状动脉支架的首例人体图像。
JACC Cardiovasc Interv. 2018 Dec 10;11(23):2427-2430. doi: 10.1016/j.jcin.2018.09.022.
3
Feasibility and safety of the second-generation, frequency domain optical coherence tomography (FD-OCT): a multicenter study.第二代频域光学相干断层扫描（FD-OCT）的可行性与安全性：一项多中心研究
J Invasive Cardiol. 2012 May;24(5):206-9.
4
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation.血管内光学相干断层扫描研究的获取、测量和报告的共识标准：来自血管内光学相干断层扫描标准化和验证国际工作组的报告。
J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72. doi: 10.1016/j.jacc.2011.09.079.
5
Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI).药物洗脱支架疗效的血管造影与血管内超声参数的荟萃分析（来自TAXUS IV、V和VI）。
Am J Cardiol. 2007 Aug 15;100(4):621-6. doi: 10.1016/j.amjcard.2007.03.076. Epub 2007 Jun 29.